FP7H2020HORIZON
Glaxosmithkline Investigacion y Desarrollo SL
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 17
- As coordinator
- 4
- EU contribution (CORDIS)
- EUR 5,965,943
- Active
- 2011 to 2025
Projects
17 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| PIAPhotocatalytic Industrial Applications | HORIZON | 2025 | Participant | Not stated |
| NAVIPPNew AntiVirals for Infections with Pandemic Potential | HORIZON | 2024 | Participant | EUR 1,144,406 |
| ITHEMYCNovel immunotherapies for tuberculosis and other mycobacterial diseases | HORIZON | 2023 | Participant | EUR 760,000 |
| ERA4TBEUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | H2020 | 2020 | Participant | EUR 0 |
| LYMPHVECsDevelopment of lipid nanoparticles based on solid matrix for Benznidazole oral delivery targeting to the lymphatic system to treat Chagas disease | H2020 | 2019 | Coordinator | EUR 158,122 |
| GNA NOWNOVEL GRAM-NEGATIVE ANTIBIOTIC NOW | H2020 | 2019 | Participant | EUR 0 |
| TRIC-TBBoosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | H2020 | 2019 | Participant | EUR 0 |
| anTBioticAnTBiotic – progressing TB drug candidates to clinical proof of concept | H2020 | 2017 | Coordinator | EUR 704,871 |
| I-CONSENTImproving the guidelines for Informed Consent, including vulnerable populations, under a gender perspective | H2020 | 2017 | Third party | Not stated |
| NAREBNanotherapeutics for antibiotic resistant emerging bacterial pathogens | FP7 | 2014 | Participant | EUR 810,480 |
| COOPERA-TBHit to lead optimisation of novel anti-TB scaffolds through an academic-industrial partnership | H2020 | 2014 | Participant | EUR 15,400 |
| PARAMETA systematic analysis of parasite metabolism - from metabolism to intervention | FP7 | 2012 | Participant | EUR 196,966 |
| FISHFORPHARMATraining Network on Zebrafish Infection Models for Pharmaceutical Screens | FP7 | 2012 | Participant | EUR 196,966 |
| OPENMEDCHEMMedicinal Chemistry Open Innovation Doctorates | FP7 | 2012 | Participant | EUR 341,973 |
| PREDICT-TBModel-based preclinical development of anti-tuberculosis drug combinations | FP7 | 2012 | Coordinator | Not stated |
| ORCHIDOpen Collaborative Model for Tuberculosis Lead Optimisation | FP7 | 2011 | Coordinator | EUR 1,380,350 |
| UPSTREAMEuropean Research Training in the Ubiquitin Proteasome System | FP7 | 2011 | Participant | EUR 256,410 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.